Global Drug-Eluting Stents Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Drug-Eluting Stents market report explains the definition, types, applications, major countries, and major players of the Drug-Eluting Stents market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Medtronic Inc

    • Abbott

    • Cook Medical

    • Biosensors International

    • Terumo

    • AlviMedica Medical Technologies

    • Balton

    • Sino Medical

    • Liaoning Biomedical Materials R&D Center Co Ltd (LBC)

    • Boston Scientific

    • Biotronik

    • Shandong JW Medical

    • MicroPort Scientific Corporation

    • Lepu Medical

    • Beijing AMSINO

    By Type:

    • Rapamycin

    • Paclitaxel

    • Everolimus

    • Others

    By End-User:

    • Angina Pectoris

    • Myocardial Infarction

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Drug-Eluting Stents Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Drug-Eluting Stents Outlook to 2028- Original Forecasts

    • 2.2 Drug-Eluting Stents Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Drug-Eluting Stents Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Drug-Eluting Stents Market- Recent Developments

    • 6.1 Drug-Eluting Stents Market News and Developments

    • 6.2 Drug-Eluting Stents Market Deals Landscape

    7 Drug-Eluting Stents Raw Materials and Cost Structure Analysis

    • 7.1 Drug-Eluting Stents Key Raw Materials

    • 7.2 Drug-Eluting Stents Price Trend of Key Raw Materials

    • 7.3 Drug-Eluting Stents Key Suppliers of Raw Materials

    • 7.4 Drug-Eluting Stents Market Concentration Rate of Raw Materials

    • 7.5 Drug-Eluting Stents Cost Structure Analysis

      • 7.5.1 Drug-Eluting Stents Raw Materials Analysis

      • 7.5.2 Drug-Eluting Stents Labor Cost Analysis

      • 7.5.3 Drug-Eluting Stents Manufacturing Expenses Analysis

    8 Global Drug-Eluting Stents Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Drug-Eluting Stents Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Drug-Eluting Stents Export by Region (Top 10 Countries) (2017-2028)

    9 Global Drug-Eluting Stents Market Outlook by Types and Applications to 2022

    • 9.1 Global Drug-Eluting Stents Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Rapamycin Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Paclitaxel Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Everolimus Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Drug-Eluting Stents Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Angina Pectoris Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Myocardial Infarction Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Drug-Eluting Stents Market Analysis and Outlook till 2022

    • 10.1 Global Drug-Eluting Stents Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Drug-Eluting Stents Consumption (2017-2022)

      • 10.2.2 Canada Drug-Eluting Stents Consumption (2017-2022)

      • 10.2.3 Mexico Drug-Eluting Stents Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Drug-Eluting Stents Consumption (2017-2022)

      • 10.3.2 UK Drug-Eluting Stents Consumption (2017-2022)

      • 10.3.3 Spain Drug-Eluting Stents Consumption (2017-2022)

      • 10.3.4 Belgium Drug-Eluting Stents Consumption (2017-2022)

      • 10.3.5 France Drug-Eluting Stents Consumption (2017-2022)

      • 10.3.6 Italy Drug-Eluting Stents Consumption (2017-2022)

      • 10.3.7 Denmark Drug-Eluting Stents Consumption (2017-2022)

      • 10.3.8 Finland Drug-Eluting Stents Consumption (2017-2022)

      • 10.3.9 Norway Drug-Eluting Stents Consumption (2017-2022)

      • 10.3.10 Sweden Drug-Eluting Stents Consumption (2017-2022)

      • 10.3.11 Poland Drug-Eluting Stents Consumption (2017-2022)

      • 10.3.12 Russia Drug-Eluting Stents Consumption (2017-2022)

      • 10.3.13 Turkey Drug-Eluting Stents Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Drug-Eluting Stents Consumption (2017-2022)

      • 10.4.2 Japan Drug-Eluting Stents Consumption (2017-2022)

      • 10.4.3 India Drug-Eluting Stents Consumption (2017-2022)

      • 10.4.4 South Korea Drug-Eluting Stents Consumption (2017-2022)

      • 10.4.5 Pakistan Drug-Eluting Stents Consumption (2017-2022)

      • 10.4.6 Bangladesh Drug-Eluting Stents Consumption (2017-2022)

      • 10.4.7 Indonesia Drug-Eluting Stents Consumption (2017-2022)

      • 10.4.8 Thailand Drug-Eluting Stents Consumption (2017-2022)

      • 10.4.9 Singapore Drug-Eluting Stents Consumption (2017-2022)

      • 10.4.10 Malaysia Drug-Eluting Stents Consumption (2017-2022)

      • 10.4.11 Philippines Drug-Eluting Stents Consumption (2017-2022)

      • 10.4.12 Vietnam Drug-Eluting Stents Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Drug-Eluting Stents Consumption (2017-2022)

      • 10.5.2 Colombia Drug-Eluting Stents Consumption (2017-2022)

      • 10.5.3 Chile Drug-Eluting Stents Consumption (2017-2022)

      • 10.5.4 Argentina Drug-Eluting Stents Consumption (2017-2022)

      • 10.5.5 Venezuela Drug-Eluting Stents Consumption (2017-2022)

      • 10.5.6 Peru Drug-Eluting Stents Consumption (2017-2022)

      • 10.5.7 Puerto Rico Drug-Eluting Stents Consumption (2017-2022)

      • 10.5.8 Ecuador Drug-Eluting Stents Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Drug-Eluting Stents Consumption (2017-2022)

      • 10.6.2 Kuwait Drug-Eluting Stents Consumption (2017-2022)

      • 10.6.3 Oman Drug-Eluting Stents Consumption (2017-2022)

      • 10.6.4 Qatar Drug-Eluting Stents Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Drug-Eluting Stents Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Drug-Eluting Stents Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Drug-Eluting Stents Consumption (2017-2022)

      • 10.7.2 South Africa Drug-Eluting Stents Consumption (2017-2022)

      • 10.7.3 Egypt Drug-Eluting Stents Consumption (2017-2022)

      • 10.7.4 Algeria Drug-Eluting Stents Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Drug-Eluting Stents Consumption (2017-2022)

      • 10.8.2 New Zealand Drug-Eluting Stents Consumption (2017-2022)

    11 Global Drug-Eluting Stents Competitive Analysis

    • 11.1 Medtronic Inc

      • 11.1.1 Medtronic Inc Company Details

      • 11.1.2 Medtronic Inc Drug-Eluting Stents Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Medtronic Inc Drug-Eluting Stents Main Business and Markets Served

      • 11.1.4 Medtronic Inc Drug-Eluting Stents Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Abbott

      • 11.2.1 Abbott Company Details

      • 11.2.2 Abbott Drug-Eluting Stents Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Abbott Drug-Eluting Stents Main Business and Markets Served

      • 11.2.4 Abbott Drug-Eluting Stents Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Cook Medical

      • 11.3.1 Cook Medical Company Details

      • 11.3.2 Cook Medical Drug-Eluting Stents Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Cook Medical Drug-Eluting Stents Main Business and Markets Served

      • 11.3.4 Cook Medical Drug-Eluting Stents Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Biosensors International

      • 11.4.1 Biosensors International Company Details

      • 11.4.2 Biosensors International Drug-Eluting Stents Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Biosensors International Drug-Eluting Stents Main Business and Markets Served

      • 11.4.4 Biosensors International Drug-Eluting Stents Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Terumo

      • 11.5.1 Terumo Company Details

      • 11.5.2 Terumo Drug-Eluting Stents Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Terumo Drug-Eluting Stents Main Business and Markets Served

      • 11.5.4 Terumo Drug-Eluting Stents Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 AlviMedica Medical Technologies

      • 11.6.1 AlviMedica Medical Technologies Company Details

      • 11.6.2 AlviMedica Medical Technologies Drug-Eluting Stents Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 AlviMedica Medical Technologies Drug-Eluting Stents Main Business and Markets Served

      • 11.6.4 AlviMedica Medical Technologies Drug-Eluting Stents Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Balton

      • 11.7.1 Balton Company Details

      • 11.7.2 Balton Drug-Eluting Stents Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Balton Drug-Eluting Stents Main Business and Markets Served

      • 11.7.4 Balton Drug-Eluting Stents Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Sino Medical

      • 11.8.1 Sino Medical Company Details

      • 11.8.2 Sino Medical Drug-Eluting Stents Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Sino Medical Drug-Eluting Stents Main Business and Markets Served

      • 11.8.4 Sino Medical Drug-Eluting Stents Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Liaoning Biomedical Materials R&D Center Co Ltd (LBC)

      • 11.9.1 Liaoning Biomedical Materials R&D Center Co Ltd (LBC) Company Details

      • 11.9.2 Liaoning Biomedical Materials R&D Center Co Ltd (LBC) Drug-Eluting Stents Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Liaoning Biomedical Materials R&D Center Co Ltd (LBC) Drug-Eluting Stents Main Business and Markets Served

      • 11.9.4 Liaoning Biomedical Materials R&D Center Co Ltd (LBC) Drug-Eluting Stents Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Boston Scientific

      • 11.10.1 Boston Scientific Company Details

      • 11.10.2 Boston Scientific Drug-Eluting Stents Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Boston Scientific Drug-Eluting Stents Main Business and Markets Served

      • 11.10.4 Boston Scientific Drug-Eluting Stents Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Biotronik

      • 11.11.1 Biotronik Company Details

      • 11.11.2 Biotronik Drug-Eluting Stents Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Biotronik Drug-Eluting Stents Main Business and Markets Served

      • 11.11.4 Biotronik Drug-Eluting Stents Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Shandong JW Medical

      • 11.12.1 Shandong JW Medical Company Details

      • 11.12.2 Shandong JW Medical Drug-Eluting Stents Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Shandong JW Medical Drug-Eluting Stents Main Business and Markets Served

      • 11.12.4 Shandong JW Medical Drug-Eluting Stents Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 MicroPort Scientific Corporation

      • 11.13.1 MicroPort Scientific Corporation Company Details

      • 11.13.2 MicroPort Scientific Corporation Drug-Eluting Stents Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 MicroPort Scientific Corporation Drug-Eluting Stents Main Business and Markets Served

      • 11.13.4 MicroPort Scientific Corporation Drug-Eluting Stents Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 Lepu Medical

      • 11.14.1 Lepu Medical Company Details

      • 11.14.2 Lepu Medical Drug-Eluting Stents Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 Lepu Medical Drug-Eluting Stents Main Business and Markets Served

      • 11.14.4 Lepu Medical Drug-Eluting Stents Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    • 11.15 Beijing AMSINO

      • 11.15.1 Beijing AMSINO Company Details

      • 11.15.2 Beijing AMSINO Drug-Eluting Stents Sales, Price, Value and Gross Profit (2017-2022)

      • 11.15.3 Beijing AMSINO Drug-Eluting Stents Main Business and Markets Served

      • 11.15.4 Beijing AMSINO Drug-Eluting Stents Product Portfolio

      • 11.15.5 Recent Research and Development Strategies

    12 Global Drug-Eluting Stents Market Outlook by Types and Applications to 2028

    • 12.1 Global Drug-Eluting Stents Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Rapamycin Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Paclitaxel Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Everolimus Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Drug-Eluting Stents Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Angina Pectoris Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Myocardial Infarction Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Drug-Eluting Stents Market Analysis and Outlook to 2028

    • 13.1 Global Drug-Eluting Stents Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.2.2 Canada Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Drug-Eluting Stents Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.3.2 UK Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.3.3 Spain Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.3.5 France Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.3.6 Italy Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.3.8 Finland Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.3.9 Norway Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.3.11 Poland Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.3.12 Russia Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Drug-Eluting Stents Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.4.2 Japan Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.4.3 India Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Drug-Eluting Stents Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.5.3 Chile Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.5.6 Peru Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Drug-Eluting Stents Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.6.3 Oman Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Drug-Eluting Stents Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Drug-Eluting Stents Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Drug-Eluting Stents Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Drug-Eluting Stents Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Drug-Eluting Stents

    • Figure of Drug-Eluting Stents Picture

    • Table Global Drug-Eluting Stents Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Drug-Eluting Stents Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Rapamycin Consumption and Growth Rate (2017-2022)

    • Figure Global Paclitaxel Consumption and Growth Rate (2017-2022)

    • Figure Global Everolimus Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Angina Pectoris Consumption and Growth Rate (2017-2022)

    • Figure Global Myocardial Infarction Consumption and Growth Rate (2017-2022)

    • Figure Global Drug-Eluting Stents Consumption by Country (2017-2022)

    • Table North America Drug-Eluting Stents Consumption by Country (2017-2022)

    • Figure United States Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure Canada Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure Mexico Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Table Europe Drug-Eluting Stents Consumption by Country (2017-2022)

    • Figure Germany Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure UK Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure Spain Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure Belgium Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure France Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure Italy Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure Denmark Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure Finland Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure Norway Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure Sweden Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure Poland Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure Russia Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure Turkey Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Table APAC Drug-Eluting Stents Consumption by Country (2017-2022)

    • Figure China Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure Japan Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure India Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure South Korea Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure Thailand Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure Singapore Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure Philippines Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Table South America Drug-Eluting Stents Consumption by Country (2017-2022)

    • Figure Brazil Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure Colombia Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure Chile Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure Argentina Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure Peru Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Table GCC Drug-Eluting Stents Consumption by Country (2017-2022)

    • Figure Bahrain Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure Oman Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure Qatar Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Table Africa Drug-Eluting Stents Consumption by Country (2017-2022)

    • Figure Nigeria Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure South Africa Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure Egypt Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure Algeria Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Table Oceania Drug-Eluting Stents Consumption by Country (2017-2022)

    • Figure Australia Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Drug-Eluting Stents Consumption and Growth Rate (2017-2022)

    • Table Medtronic Inc Company Details

    • Table Medtronic Inc Drug-Eluting Stents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medtronic Inc Drug-Eluting Stents Main Business and Markets Served

    • Table Medtronic Inc Drug-Eluting Stents Product Portfolio

    • Table Abbott Company Details

    • Table Abbott Drug-Eluting Stents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Drug-Eluting Stents Main Business and Markets Served

    • Table Abbott Drug-Eluting Stents Product Portfolio

    • Table Cook Medical Company Details

    • Table Cook Medical Drug-Eluting Stents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cook Medical Drug-Eluting Stents Main Business and Markets Served

    • Table Cook Medical Drug-Eluting Stents Product Portfolio

    • Table Biosensors International Company Details

    • Table Biosensors International Drug-Eluting Stents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biosensors International Drug-Eluting Stents Main Business and Markets Served

    • Table Biosensors International Drug-Eluting Stents Product Portfolio

    • Table Terumo Company Details

    • Table Terumo Drug-Eluting Stents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Terumo Drug-Eluting Stents Main Business and Markets Served

    • Table Terumo Drug-Eluting Stents Product Portfolio

    • Table AlviMedica Medical Technologies Company Details

    • Table AlviMedica Medical Technologies Drug-Eluting Stents Sales, Price, Value and Gross Profit (2017-2022)

    • Table AlviMedica Medical Technologies Drug-Eluting Stents Main Business and Markets Served

    • Table AlviMedica Medical Technologies Drug-Eluting Stents Product Portfolio

    • Table Balton Company Details

    • Table Balton Drug-Eluting Stents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Balton Drug-Eluting Stents Main Business and Markets Served

    • Table Balton Drug-Eluting Stents Product Portfolio

    • Table Sino Medical Company Details

    • Table Sino Medical Drug-Eluting Stents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sino Medical Drug-Eluting Stents Main Business and Markets Served

    • Table Sino Medical Drug-Eluting Stents Product Portfolio

    • Table Liaoning Biomedical Materials R&D Center Co Ltd (LBC) Company Details

    • Table Liaoning Biomedical Materials R&D Center Co Ltd (LBC) Drug-Eluting Stents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Liaoning Biomedical Materials R&D Center Co Ltd (LBC) Drug-Eluting Stents Main Business and Markets Served

    • Table Liaoning Biomedical Materials R&D Center Co Ltd (LBC) Drug-Eluting Stents Product Portfolio

    • Table Boston Scientific Company Details

    • Table Boston Scientific Drug-Eluting Stents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boston Scientific Drug-Eluting Stents Main Business and Markets Served

    • Table Boston Scientific Drug-Eluting Stents Product Portfolio

    • Table Biotronik Company Details

    • Table Biotronik Drug-Eluting Stents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biotronik Drug-Eluting Stents Main Business and Markets Served

    • Table Biotronik Drug-Eluting Stents Product Portfolio

    • Table Shandong JW Medical Company Details

    • Table Shandong JW Medical Drug-Eluting Stents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shandong JW Medical Drug-Eluting Stents Main Business and Markets Served

    • Table Shandong JW Medical Drug-Eluting Stents Product Portfolio

    • Table MicroPort Scientific Corporation Company Details

    • Table MicroPort Scientific Corporation Drug-Eluting Stents Sales, Price, Value and Gross Profit (2017-2022)

    • Table MicroPort Scientific Corporation Drug-Eluting Stents Main Business and Markets Served

    • Table MicroPort Scientific Corporation Drug-Eluting Stents Product Portfolio

    • Table Lepu Medical Company Details

    • Table Lepu Medical Drug-Eluting Stents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lepu Medical Drug-Eluting Stents Main Business and Markets Served

    • Table Lepu Medical Drug-Eluting Stents Product Portfolio

    • Table Beijing AMSINO Company Details

    • Table Beijing AMSINO Drug-Eluting Stents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Beijing AMSINO Drug-Eluting Stents Main Business and Markets Served

    • Table Beijing AMSINO Drug-Eluting Stents Product Portfolio

    • Figure Global Rapamycin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Paclitaxel Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Everolimus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Angina Pectoris Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Myocardial Infarction Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Drug-Eluting Stents Consumption Forecast by Country (2022-2028)

    • Table North America Drug-Eluting Stents Consumption Forecast by Country (2022-2028)

    • Figure United States Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Drug-Eluting Stents Consumption Forecast by Country (2022-2028)

    • Figure Germany Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Drug-Eluting Stents Consumption Forecast by Country (2022-2028)

    • Figure China Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Drug-Eluting Stents Consumption Forecast by Country (2022-2028)

    • Figure Brazil Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Drug-Eluting Stents Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Drug-Eluting Stents Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Drug-Eluting Stents Consumption Forecast by Country (2022-2028)

    • Figure Australia Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Drug-Eluting Stents Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.